The model was refined against one half map, and FSC curves were calculated between this model and the final cryo-EM map (full dataset, blue) of the outcome of model refinement with a half map versus the same map (orange), and of the outcome of model refinement with a half map versus the other half map (green)
those with more advanced beta cell dysfunction may experience less benefit from GLP-1 therapy, as the medication relies on functional beta cells to stimulate insulin secretion
It helps to examine the overall structure of an operators lobby
Where the two part ways is in their chemistry and that chemistry is the reason their dosing instructions look so different
While this type of cancer was only found in rodent studies (not in humans), people who have a personal or family history of thyroid cancer, including medullary thyroid carcinoma (MTC), or MEN2 syndrome shouldn't take GLP-1 medications like Mounjaro or Ozempic
Therefore, this hormone could be a promising candidate for combination therapy with GLP-1 for better control of T2D
